Heramed Ltd - Asset Resilience Ratio
Heramed Ltd (HMD) has an Asset Resilience Ratio of 0.83% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See HMD working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how Heramed Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Heramed Ltd asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down Heramed Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Heramed Ltd total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$23.01K | 0.83% |
| Total Liquid Assets | AU$23.01K | 0.83% |
Asset Resilience Insights
- Limited Liquidity: Heramed Ltd maintains only 0.83% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Heramed Ltd Industry Peers by Asset Resilience Ratio
Compare Heramed Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Medartis Holding AG
SW:MED |
Medical Devices | 0.00% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Mediantechn
PA:ALMDT |
Medical Devices | 0.45% |
Annual Asset Resilience Ratio for Heramed Ltd (2017–2024)
The table below shows the annual Asset Resilience Ratio data for Heramed Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.83% | AU$23.01K ≈ $16.28K |
AU$2.78 Million ≈ $1.96 Million |
-0.63pp |
| 2023-12-31 | 1.46% | AU$29.38K ≈ $20.79K |
AU$2.01 Million ≈ $1.43 Million |
+0.92pp |
| 2022-12-31 | 0.54% | AU$22.51K ≈ $15.93K |
AU$4.19 Million ≈ $2.96 Million |
-0.01pp |
| 2021-12-31 | 0.55% | AU$25.27K ≈ $17.88K |
AU$4.57 Million ≈ $3.24 Million |
-0.68pp |
| 2020-12-31 | 1.23% | AU$39.06K ≈ $27.64K |
AU$3.17 Million ≈ $2.25 Million |
+0.22pp |
| 2019-12-31 | 1.02% | AU$36.61K ≈ $25.90K |
AU$3.61 Million ≈ $2.55 Million |
+0.85pp |
| 2018-12-31 | 0.16% | AU$6.86K ≈ $4.85K |
AU$4.27 Million ≈ $3.02 Million |
-0.24pp |
| 2017-12-31 | 0.40% | AU$5.00K ≈ $3.53K |
AU$1.25 Million ≈ $882.84K |
-- |
About Heramed Ltd
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the … Read more